HomeENVB • NASDAQ
add
Enveric Biosciences Inc
Previous close
$0.32
Day range
$0.32 - $0.35
Year range
$0.31 - $2.92
Market cap
3.39M USD
Avg Volume
1.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.08M | -39.59% |
Net income | -2.08M | 26.16% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.00M | 40.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.11M | -27.07% |
Total assets | 4.79M | -27.63% |
Total liabilities | 839.17K | -79.94% |
Total equity | 3.95M | — |
Shares outstanding | 9.94M | — |
Price to book | 0.73 | — |
Return on assets | -96.07% | — |
Return on capital | -111.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.08M | 26.16% |
Cash from operations | -927.07K | 66.17% |
Cash from investing | — | — |
Cash from financing | 517.69K | 593.04% |
Net change in cash | -390.87K | 86.11% |
Free cash flow | -232.68K | 89.23% |
About
Founded
1994
Headquarters
Website
Employees
7
